NVNO enVVeno Medical Corporation

-

enVVeno Medical Reported Earnings

Thursday, July 30, 2026 · 12:00 AM ET

enVVeno Medical (NVNO) reported a loss of $5.37 per share on revenue of $0.00 million for the second quarter ended June 2026. .

enVVeno Medical Corporation is a medical device company. It focuses in the treatment of venous disease. enVVeno Medical Corporation, formerly known as Hancock Jaffe Laboratories Inc., is based in IRVINE, CA.

Earnings Whisper Grade
Power Rating
Reported Earnings
($5.37)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth-1,527.3 %
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth